An Open-label Study of XEN1101 in Epilepsy

NCT05718817 · clinicaltrials.gov ↗

PHASE3

Phase

ENROLLING_BY_INVITATION

Status

880

Enrollment

INDUSTRY

Sponsor class

Conditions

Focal Epilepsy
Tonic-Clonic Seizures

Interventions

DRUG: XEN1101

Sponsor

Xenon Pharmaceuticals Inc.

Collaborators

[object Object]